Leukemia
Disease State Hub
Featured
04/22/2024
The FDA previously approved lisocabtagene maraleucel as a second-line treatment option for adult patients with large B-cell lymphoma in June 2022.
04/22/2024
04/11/2024
While most cases of chronic lymphocytic leukemia are appropriately managed with medication therapy, rare cases require the use of additional treatment modalities. Which of these other treatments have you...
04/11/2024
03/30/2024
Are you familiar with the patient populations most commonly diagnosed with chronic lymphocytic leukemia? Take this pop quiz to test your knowledge.
03/30/2024
Interactive Features
04/11/2024
While most cases of chronic lymphocytic leukemia are appropriately managed with medication therapy, rare cases require the use of additional treatment modalities. Which of these other treatments have you...
04/11/2024
03/30/2024
Are you familiar with the patient populations most commonly diagnosed with chronic lymphocytic leukemia? Take this pop quiz to test your knowledge.
03/30/2024
02/27/2024
The American Cancer Society annually projects the number of new leukemia diagnoses in the United States. Which type of leukemia is projected to have the most diagnoses in 2024? Take the quiz to find out! ...
02/27/2024
02/12/2024
The survival outcomes for patients diagnosed with this chronic lymphocytic leukemia complication have remained poor for decades. Can you name the complication? Take the quiz to find out!
02/12/2024
11/28/2023
Quizartinib is FDA-approved to treat patients with AML and which type of genetic mutation? Take this quiz to find out!
11/28/2023
Clinical Insights
12/29/2023
In this podcast, Pinkal Desai, MD, discusses the impact of previous chemotherapy and/or radiation exposure in patients who go on to develop acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS),...
12/29/2023
